Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0262970001
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Authorization By Interim Order Revoked | 02516691 | HOFFMANN-LA ROCHE LIMITED | CASIRIVIMAB AND IMDEVIMAB | Human | Yes | SCHEDULE D | 2 | CASIRIVIMAB | 300 MG / 2.5 ML |
| Authorization By Interim Order Revoked | 02516691 | HOFFMANN-LA ROCHE LIMITED | CASIRIVIMAB AND IMDEVIMAB | Human | Yes | PRESCRIPTION | 2 | CASIRIVIMAB | 300 MG / 2.5 ML |
| Authorization By Interim Order Revoked | 02516691 | HOFFMANN-LA ROCHE LIMITED | CASIRIVIMAB AND IMDEVIMAB | Human | Yes | COVID-19 - IO - AUTHORIZATION | 2 | CASIRIVIMAB | 300 MG / 2.5 ML |
| Authorization By Interim Order Revoked | 02516705 | HOFFMANN-LA ROCHE LIMITED | CASIRIVIMAB AND IMDEVIMAB | Human | Yes | SCHEDULE D | 2 | IMDEVIMAB | 1332 MG / 11.1 ML |
| Authorization By Interim Order Revoked | 02516705 | HOFFMANN-LA ROCHE LIMITED | CASIRIVIMAB AND IMDEVIMAB | Human | Yes | PRESCRIPTION | 2 | IMDEVIMAB | 1332 MG / 11.1 ML |
| Authorization By Interim Order Revoked | 02516705 | HOFFMANN-LA ROCHE LIMITED | CASIRIVIMAB AND IMDEVIMAB | Human | Yes | COVID-19 - IO - AUTHORIZATION | 2 | IMDEVIMAB | 1332 MG / 11.1 ML |
Application information
Related information
Contact us
Version 4.0.3